FDA’s marketing denials for Myblu ‘very ominous news’ for US vaping industry

The company that makes the Myblu vaping pod has a 30-day window to challenge the US Food and Drug Administration (FDA)’s denial of premarket tobacco applications (PMTAs) for the device and flavoured refills.

The 30-day deadline for a legal challenge began from the date of the marketing denial orders for the Myblu device kit and six flavours, including Intense Tobacco, Intense Tobacco Chill and Gold Leaf. It is the first such denial issued by the FDA in six months, and American Vaping Association (AVA) president Gregory Conley said it “looks like very ominous news”.

Read full article
I'm already a subscriber
Author default picture


This article was written by one of ECigIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual vaping markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization